Skip to main content
WeightCited

Probiotics (Lactobacillus gasseri)
Probiotics (Lactobacillus gasseri)

gut_health

别名: L. gasseri SBT2055, L. gasseri BNR17, Lactobacillus gasseri

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dprobiotics\u002Dlactobacillus\u002Dgasseri'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

About

A strain-specific probiotic with the most consistent clinical evidence among probiotic strains for supporting healthy visceral fat levels. A well-designed 12-week RCT using abdominal CT imaging demonstrated L. gasseri SBT2055 may support healthy body weight and abdominal fat distribution.

How It Works

Strain-specific probiotic that modulates the gut-brain-adipose axis. L. gasseri SBT2055 reduces dietary fat absorption by increasing fecal fat excretion (by ~8-18%), reduces pro-inflammatory cytokine production in visceral adipose tissue, and modulates bile acid metabolism. Also influences leptin and ghrelin signaling through short-chain fatty acid (SCFA) production and vagal nerve pathways.

Evidence For Conditions

健康状况 等级 研究数量 受试者
Abdominal Fat Reduction A 5 400 查看 →
Obesity C 15 1500 查看 →

Side Effects

  • Bloating (initial colonization)
  • Gas
  • GI discomfort (transient)

Drug & Supplement Interactions

  • Immunosuppressants (probiotics may stimulate immune system)
  • Antibiotics (may reduce probiotic effectiveness)

请务必告知您的医疗保健提供者您正在服用的所有补充剂。

Related Ingredients

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。